CA-USERTESTING
26.7.2022 09:02:12 CEST | Business Wire | Press release
UserTesting (NYSE: USER), a leader in video-based human insight , today announced that UserTesting CEO Andy MacMillan will be joining host Nick Murray, Co-Director Startup Grind Scotland and Strategic Partnerships Manager, Metanomic, for a discussion focused on topics that include empathy in leadership, and what makes Edinburgh an ideal location as a European headquarters for technology companies. This event is taking place on Thursday, August 4, at UserTesting’s European headquarters in Edinburgh.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220726005085/en/
Attendees also can hear what Scotland can learn from Silicon Valley’s mindset, the value of customer insights in helping to drive business decisions during challenging economic periods, and lessons learned from rapidly growing a SaaS company through an IPO.
Discussion Details:
- Date: Thursday, August 4, 2022
- Time: 6:00 p.m. to 9:00 p.m., BST
- Location: UserTesting EMEA Headquarters, 2nd Floor, 7 Exchange Crescent, Edinburgh, EH3 8AN
- Cost: 6 GBP public, Free for UserTesting team members (prior registration required)
-
Speakers:
- Andy MacMillan, CEO of UserTesting
- Nick Murray, Host and Co-Director Startup Grind Scotland
"Community gatherings with globally-proven industry experts are critical to developing Scotland's entrepreneurial ecosystem," said Nick Murray, Co-Director of Startup Grind Scotland. "Our first interview with Andy in Silicon Valley this April was a significant mindset shift for the 20 Scottish founders we took to the entrepreneurship mecca. With the Scottish Government announcing Scotland's Tech Scaler Hubs this month, now is the perfect time to look internationally to find best practices and learn from those who have been there before. This interview will broaden the horizons of what's possible for Scottish businesses through the eyes of someone who has had incredible success in scaling a SAAS business to a global entity."
“Selecting Edinburgh was the right choice for UserTesting’s European headquarters, and we are excited to be a part of this event, highlighting the value we have found in establishing offices here,” said Andy MacMillan, CEO of UserTesting. “UserTesting is proud to support Edinburgh’s, and Scotland’s, growing technology scene. There are great opportunities for companies in Scotland, due to the local education system, partnership opportunities with local government agencies, and the local talent, which is what global technology companies are looking for today.”
About UserTesting
UserTesting (NYSE: USER) has fundamentally changed the way organizations get insights from customers with fast, opt-in feedback and experience capture technology. The UserTesting Human Insight Platform taps into our global network of real people and generates video-based recorded experiences, so anyone in an organization can directly ask questions, hear what users say, see what they mean, and understand what it’s actually like to be a customer. Unlike approaches that track user behavior then try to infer what that behavior means, UserTesting reduces guesswork and brings customer experience data to life with human insight. UserTesting has approximately 2,500 customers, including more than half of the world’s top 100 most valuable brands according to Forbes. UserTesting is headquartered in San Francisco, California. To learn more, visit www.usertesting.com
.
About Startup Grind Scotland
Startup Grind is the world's largest community of startups, founders, innovators, and creators based in 125+ countries with 600 chapters worldwide. Startup Grind Scotland is committed to supporting Scotland's vibrant entrepreneurial community, hosting fireside chats and panel conversations with some of Scotland's most influential and exciting business leaders. Past speakers include Mark Logan (Scotland's Chief Entrepreneur and ex-Skyscanner COO), Darina Garland (co-founder, Ooni) and Evelyn McDonald (CEO, Scottish EDGE).
View source version on businesswire.com: https://www.businesswire.com/news/home/20220726005085/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom